Axial Biotherapeutics

Company Summary

Axial Biotherapeutics is a biopharmaceutical company harnessing the link between the human gut microbiome and the central nervous system to develop a new class of biotherapeutics to improve the quality of life for people with neurological diseases and disorders.

Year Founded:  2016

Key Executives:
• David H. Donabedian, Co-founder, CEO and Director
• Sarkis Mazmanian, Co-founder and Director

Location:  Boston, MA


Company Status:  Private

Year Invested: 2016

Investment Status:  Current